Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
4.470
+0.010 (0.22%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Silo Pharma Revenue
Silo Pharma had revenue of $18.03K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $72.10K. In the year 2025, Silo Pharma had annual revenue of $72.10K.
Revenue (ttm)
$72.10K
Revenue Growth
n/a
P/S Ratio
67.23
Revenue / Employee
$24,034
Employees
3
Market Cap
4.85M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 72.10K | - | - |
| Dec 31, 2024 | 72.10K | - | - |
| Dec 31, 2023 | 72.10K | - | - |
| Dec 31, 2022 | 72.10K | 838.00 | 1.18% |
| Dec 31, 2021 | 71.26K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bio Green Med Solution | 1.53M |
| AIM ImmunoTech | 94.00K |
| Jupiter Neurosciences | 40.45K |
| Cardio Diagnostics Holdings | 16.57K |
| Alaunos Therapeutics | 3.00K |
| Ernexa Therapeutics | 1,000.00 |
SILO News
- 2 days ago - Silo Pharma files to sell 1.91M shares of common stock for holders - TheFly
- 5 days ago - Silo Pharma Advances Growth Platforms for AI Agent Commercialization and Lead PTSD Drug Program - GlobeNewsWire
- 12 days ago - Silo Pharma subsidiary QwikAgents joins AMD AI program - TheFly
- 12 days ago - Silo Pharma's QwikAgents Joins AMD AI Developer Program to Advance Enterprise AI Agent Platform - GlobeNewsWire
- 16 days ago - Silo Pharma prices $11.7M at-the-market offering at $6.45 per share - TheFly
- 16 days ago - Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 19 days ago - Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program - GlobeNewsWire
- 27 days ago - Silo Pharma engages Resyca to conduct a robustness study for SPC-15 delivery - TheFly